🇺🇸 sinemet plus in United States
202 US adverse-event reports
Safety signals — FAERS
Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.
- Window: 22 April 2025 – 22 April 2026
- Total reports: 202
Most-reported reactions
- Drug Interaction — 37 reports (18.32%)
- Parkinson^S Disease — 30 reports (14.85%)
- Dyskinesia — 21 reports (10.4%)
- Vomiting — 19 reports (9.41%)
- Drug Ineffective — 18 reports (8.91%)
- Tremor — 17 reports (8.42%)
- Dyspnoea — 16 reports (7.92%)
- Malaise — 16 reports (7.92%)
- Dysphagia — 14 reports (6.93%)
- Musculoskeletal Stiffness — 14 reports (6.93%)
Other Neurology approved in United States
Frequently asked questions
Is sinemet plus approved in United States?
sinemet plus does not currently have US marketing authorisation in our dataset.
Who is the marketing authorisation holder for sinemet plus in United States?
Hospital de Granollers is the originator. The local marketing authorisation holder may differ — check the official source linked above.